The Role of Bacterial Infections in the Pathogenesis of Lupus
Roberto Caricchio, MD
Temple University
Grants
Target Identification in Lupus (TIL)
The Target Identification in Lupus grants provide up to $200,000/year total costs for up to 3 years. They support highly meritorious research focused on the identification and scientific and/or clinical advancement of therapeutic targets that will lead to new therapies for lupus.
2017 Funded Grants
Roberto Caricchio, MD
Temple University
Targeting the Inactive X Chromosome in Lupus
Laura Carrel, PhD
The Pennsylvania State University College of Medicine
Characterization of STING SAVI Gain of Function Mutations in Mice.
Katherine Fitzgerald, PhD
University of Massachusetts Medical School
ALCAM in Lupus
Chandra Mohan, MD, PhD
University of Houston
Defining New Targets in lupus Through Identification of Non-coding SNPs
Peter A. Nigovric, MD
Brigham and Women's Hospital, Inc
Targeting Endogenous Glomerular Repair in Lupus Nephritis
Janos Peti-Peterdi, MD, PhD
Keck School of Medicine of University of Southern California
Finding Druggable Pathways Affected by the R90H-NCF1 SLE Risk Variants
Betty Tsao, PhD
Medical University of South Carolina
2016 Funded Grants
Dissecting the Effector Function of Pathogenic Tfh Cells in Human Lupus
Rong Fan, PhD
Yale University
BRISC DUB Activity as a Novel Target for Lupus
Roger Greenberg, MD, PhD
University of Pennsylvania
A Novel Target for Neutrophil NETosis in Lupus Skin Inflammation
Ming-Lin Liu, MD, PhD
University of Pennsylvania Health System
Therapeutic Inhibitors of Antigen Presentation Pathways in SLE
Mark J. Mamula, PhD
Yale University
Targeting Follicular Helper CD4 T cells in SLE
Laurence Morel, PhD
University of Florida College of Medicine
TLR9 Regulates Axl Dependent Migration of Autoreactive B Cells
Kerstin Nündel, PhD
University of Massachusetts Medical School
because the Lupus Research Alliance board of directors funds all administrative and fundraising costs